SEP 25·SEC EDGARLow
He Junli purchased $394K of HRGN
He Junli (CEO) purchased 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. (HRGN) at an average of $1.07 ($1.05–$2.15, $0.39M total) across 2 trades over 2026-09-11 to 2026-09-15.
StockOTC · US · USDConsumer Defensive · Packaged Foods
$HRGN
Harvard Apparatus Regenerative Technology, Inc.
Price · $HRGNvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $HRGN in the last 7 days.
Insider · 30dAll trades →
- Buys
- $394K 2 txs
- Sells
- — 0 txs
He Junli2× · $394K
10b5-1 share of filings0%
Top stories · $HRGNMore →
SEP 14·SEC EDGAR 8-K
Harvard Apparatus Regenerative Technology, Inc. (HRGN): Entry into a Material Definitive Agreement
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the I
AUG 3·SEC EDGAR 8-K
Harvard Apparatus Regenerative Technology, Inc. (HRGN): Entry into a Material Definitive Agreement
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. May 2026 Bridge Note On May 8, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursu
HRGN sentiment & insider activity
Recent HRGN coverage spans corporate actions and insider activity.
In the last 30 days, HRGN insiders filed 2 SEC Form 4 transactions — 2 purchases ($394K) and no sales. The most active reporter was He Junli, CEO, with 2 filings.
What's driving HRGN
Insider purchase signals confidence but size is modest relative to market cap.
The capital raise adds cash but dilutes existing shareholders; modest impact on a micro‑cap.
The filing adds near-term financing and introduces dilution risk if the next qualifying equity raise occurs before maturity.
Routine shareholder-meeting voting outcomes; no new financial guidance, deal, or enforcement action disclosed.
AlphAI scores every news story that mentions HRGN with an AI model for sentiment and relevance, and aggregates insider trades from Harvard Apparatus Regenerative Technology, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $HRGN
Score
He Junli purchased $394K of HRGN
He Junli (CEO) purchased 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. (HRGN) at an average of $1.07 ($1.05–$2.15, $0.39M total) across 2 trades over 2026-09-11 to 2026-09-15.
1 min readHarvard Apparatus Regenerative Technology, Inc. (HRGN): Entry into a Material Definitive Agreement
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the I
2 min readHarvard Apparatus Regenerative Technology, Inc. (HRGN): Entry into a Material Definitive Agreement
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. May 2026 Bridge Note On May 8, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursu
2 min readHarvard Apparatus Regenerative Technology, Inc. (HRGN): Submission of Matters to a Vote of Security Holders
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. hrgn20260623_8k.htm false 0001563665 0001563665 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event repo
3 min read